GBT logo

GBT Cash From Investing

Annual CFI

$12.11 M
-$305.20 M-96.18%

December 31, 2021

Summary

Performance

1-Year Change

-96.18%

3-Year Change

+106.58%

5-Year Change

+134.6%

15-Year Change

+134.6%

GBT Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$317.31 M
GBT annual cash flow from investing activities is currently -96.18% below its historical high of $317.31 million

3-Year Low

$12.11 M
GBT annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
GBT previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
GBT next annual earnings announcement has not yet been scheduled

OtherGBTcash flowmetrics:

Annual CFF

$434.33 M
GBT annual cash flow from financing activities is $434.33 million

Annual CFO

-$256.81 M
GBT annual cash flow from operations is -$256.81 million

Annual FCF

-$260.05 M
GBT annual free cash flow is -$260.05 million

Annual CAPEX

$3.23 M
GBT annual capital expenditures is $3.23 million

Quarterly CFI

-$134.66 M
+$87.84 M+39.48%

June 30, 2022

Summary

Performance

3-Month Change

+39.48%

1-Year Change

-858.82%

3-Year Change

-623.38%

5-Year Change

-484.9%

GBT Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$108.76 M
GBT quarterly cash flow from investing activities is currently -223.82% below its historical high of $108.76 million

3-Year Low

-$222.50 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
GBT previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
GBT next earnings announcement has not yet been scheduled

OtherGBTcash flowmetrics:

Quarterly CFF

$48.60 M
GBT quarterly cash flow from financing activities is $48.60 million

Quarterly CFO

-$44.31 M
GBT quarterly cash flow from operations is -$44.31 million

Quarterly FCF

-$44.69 M
GBT quarterly free cash flow is -$44.69 million

Quarterly CAPEX

$384.00 K
GBT quarterly capital expenditures is $384.00 thousand

TTM CFI

-$390.80 M
-$152.41 M-63.93%

June 30, 2022

Summary

Performance

3-Month Change

-63.93%

1-Year Change

-339.49%

3-Year Change

-408.45%

5-Year Change

-408.45%

GBT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$317.31 M
GBT TTM cash flow from investing activities is currently -223.16% below its historical high of $317.31 million

3-Year Low

-$390.80 M
GBT TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
GBT previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
GBT next earnings announcement has not yet been scheduled

OtherGBTcash flowmetrics:

TTM CFF

$482.46 M
GBT TTM cash flow from financing activities is $482.46 million

TTM CFO

-$249.40 M
GBT TTM cash flow from operations is -$249.40 million

TTM FCF

-$251.35 M
GBT TTM free cash flow is -$251.35 million

TTM CAPEX

$1.95 M
GBT TTM capital expenditures is $1.95 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

GBT Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-96.2%-858.8%-339.5%
3 y3 years+106.6%-623.4%-408.4%
5 y5 years+134.6%-484.9%-408.4%

GBT Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+669.0%+65.2%-3327.1%at low
5 y5-year-96.2%-734.7%-223.8%+65.2%-223.2%at low
alltimeall time-96.2%-1620.7%-223.8%+65.2%-223.2%at low

Global Blood Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2022
-
-$134.66 M(-39.5%)
-$390.80 M(+63.9%)
Mar 2022
-
-$222.50 M(+1170.6%)
-$238.39 M(-2068.6%)
Dec 2021
$12.11 M(-96.2%)
-$17.51 M(+8.6%)
$12.11 M(-83.9%)
Sep 2021
-
-$16.13 M(-190.9%)
$75.23 M(-53.9%)
Jun 2021
-
$17.75 M(-36.6%)
$163.18 M(-35.8%)
Mar 2021
-
$28.00 M(-38.6%)
$254.19 M(-19.9%)
Dec 2020
$317.31 M(-512.8%)
$45.61 M(-36.5%)
$317.31 M(+8.5%)
Sep 2020
-
$71.82 M(-34.0%)
$292.33 M(+47.7%)
Jun 2020
-
$108.76 M(+19.3%)
$197.94 M(+72.3%)
Mar 2020
-
$91.13 M(+341.7%)
$114.92 M(-249.5%)
Dec 2019
-$76.86 M(-58.3%)
$20.63 M(-191.4%)
-$76.86 M(-38.9%)
Sep 2019
-
-$22.57 M(-187.7%)
-$125.78 M(-42.8%)
Jun 2019
-
$25.73 M(-125.6%)
-$220.00 M(-32.6%)
Mar 2019
-
-$100.65 M(+255.8%)
-$326.38 M(+77.2%)
Dec 2018
-$184.16 M
-$28.29 M(-75.8%)
-$184.16 M(+62.3%)
Sep 2018
-
-$116.79 M(+44.8%)
-$113.48 M(-711.1%)
Jun 2018
-
-$80.65 M(-294.0%)
$18.57 M(-75.6%)
DateAnnualQuarterlyTTM
Mar 2018
-
$41.57 M(-1.9%)
$76.20 M(-317.7%)
Dec 2017
-$35.00 M(-67.2%)
$42.38 M(+177.6%)
-$35.00 M(-80.9%)
Sep 2017
-
$15.27 M(-166.3%)
-$183.13 M(-7.8%)
Jun 2017
-
-$23.02 M(-66.9%)
-$198.55 M(+12.7%)
Mar 2017
-
-$69.63 M(-34.2%)
-$176.10 M(+64.8%)
Dec 2016
-$106.85 M(>+9900.0%)
-$105.75 M(>+9900.0%)
-$106.85 M(+7970.4%)
Sep 2016
-
-$151.00 K(-73.8%)
-$1.32 M(-5.0%)
Jun 2016
-
-$577.00 K(+52.6%)
-$1.39 M(+15.9%)
Mar 2016
-
-$378.00 K(+73.4%)
-$1.20 M(+21.0%)
Dec 2015
-$993.00 K(+159.3%)
-$218.00 K(-0.9%)
-$993.00 K(+3.0%)
Sep 2015
-
-$220.00 K(-43.0%)
-$964.00 K(+20.7%)
Jun 2015
-
-$386.00 K(+128.4%)
-$799.00 K(+49.9%)
Mar 2015
-
-$169.00 K(-10.6%)
-$533.00 K(+39.2%)
Dec 2014
-$383.00 K(-59.3%)
-$189.00 K(+243.6%)
-$383.00 K(+97.4%)
Sep 2014
-
-$55.00 K(-54.2%)
-$194.00 K(+39.6%)
Jun 2014
-
-$120.00 K(+531.6%)
-$139.00 K(+631.6%)
Mar 2014
-
-$19.00 K
-$19.00 K
Dec 2013
-$940.00 K
-
-

FAQ

  • What is Global Blood Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Global Blood Therapeutics?
  • What is Global Blood Therapeutics annual CFI year-on-year change?
  • What is Global Blood Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Global Blood Therapeutics?
  • What is Global Blood Therapeutics quarterly CFI year-on-year change?
  • What is Global Blood Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Global Blood Therapeutics?
  • What is Global Blood Therapeutics TTM CFI year-on-year change?

What is Global Blood Therapeutics annual cash flow from investing activities?

The current annual CFI of GBT is $12.11 M

What is the all time high annual CFI for Global Blood Therapeutics?

Global Blood Therapeutics all-time high annual cash flow from investing activities is $317.31 M

What is Global Blood Therapeutics annual CFI year-on-year change?

Over the past year, GBT annual cash flow from investing activities has changed by -$305.20 M (-96.18%)

What is Global Blood Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of GBT is -$134.66 M

What is the all time high quarterly CFI for Global Blood Therapeutics?

Global Blood Therapeutics all-time high quarterly cash flow from investing activities is $108.76 M

What is Global Blood Therapeutics quarterly CFI year-on-year change?

Over the past year, GBT quarterly cash flow from investing activities has changed by -$152.41 M (-858.82%)

What is Global Blood Therapeutics TTM cash flow from investing activities?

The current TTM CFI of GBT is -$390.80 M

What is the all time high TTM CFI for Global Blood Therapeutics?

Global Blood Therapeutics all-time high TTM cash flow from investing activities is $317.31 M

What is Global Blood Therapeutics TTM CFI year-on-year change?

Over the past year, GBT TTM cash flow from investing activities has changed by -$553.98 M (-339.49%)